Advertisement

Reactions Weekly

, Volume 1688, Issue 1, pp 53–53 | Cite as

Carboplatin/paclitaxel

Febrile neutropenia and acute exacerbation of interstitial lung disease: 2 case reports
Case report
  • 16 Downloads

Reference

  1. Yasuda Y, et al. The safety and efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel in the treatment of non-small cell lung cancer patients with interstitial lung disease. Japanese Journal of Clinical Oncology 48: 89-93, No. 1, 01 Jan 2018. Available from: URL: https://doi.org/10.1093/jjco/hyx142 - JapanCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations